Literature DB >> 17092604

Clinical significance of a solitary ground-glass opacity (GGO) lesion of the lung detected by chest CT.

Jin-Young Oh1, Sung-Youn Kwon, Ho-Il Yoon, Sang Min Lee, Jae-Joon Yim, Jae-Ho Lee, Chul-Gyu Yoo, Young Whan Kim, Sung Koo Han, Young-Soo Shim, Tae Jung Kim, Kyung Won Lee, Jin-Haeng Chung, Sang Hoon Jheon, Sook Whan Sung, Choon-Taek Lee.   

Abstract

Ground-glass opacity (GGO) attracts attention because of the possibility of early lung cancer. However, some lesions are reduced in size or disappear at follow-up. This study was designed to explore the natural history of solitary GGO, to determine the prevalence of malignancy and to identify factors predictive of benignity or malignancy. Solitary and focal GGO lesions [pGGO (p=pure) and mGGO (m=mixed) based on the presence of a solid component] of less than 3 cm were included. Lesions of less than 1cm were followed up by chest HRCT 3 months later and lesions over 1cm were investigated by percutaneous needle biopsy (PCNB). One hundred and eighty-six patients (69 pGGO and 117 mGGO) were enrolled. Of the 69 pGGO lesions, 7 were diagnosed as pre-malignant or malignant lesions, 3 as benign lesions and 26 pGGO lesions (37.6%) were reduced or disappeared (transient lesions) at follow-up chest HRCT. The other 33 lesions showed no significant change during follow-up. Thus, the probability of malignancy in pGGO was 7/36 (19.4%). On the other hand, of the 117 mGGO lesions, 26 were found to be malignant, 3 were diagnosed as benign and 57 lesions (48.7%) were reduced or had disappeared at follow-up chest HRCT. The other 31 lesions showed no change during follow-up, and thus the probability of malignancy in mGGO was 26/86 (30.2%). A female sex and a spiculated mGGO border were found to be related with malignancy. However, a high blood eosinophil count was strongly associated with regressing or transient mGGO, suggesting that pulmonary infiltrate with eosinophilia (PIE) might have been responsible. We recommend short-term follow-up by chest HRCT be conducted for mGGO lesions in the presence of high eosinophilia--regardless of lesion size.

Entities:  

Mesh:

Year:  2006        PMID: 17092604     DOI: 10.1016/j.lungcan.2006.09.009

Source DB:  PubMed          Journal:  Lung Cancer        ISSN: 0169-5002            Impact factor:   5.705


  40 in total

1.  Multidetector CT features of pulmonary focal ground-glass opacity: differences between benign and malignant.

Authors:  L Fan; S-Y Liu; Q-C Li; H Yu; X-S Xiao
Journal:  Br J Radiol       Date:  2011-11-29       Impact factor: 3.039

2.  Management of subsolid pulmonary nodules in CT lung cancer screening.

Authors:  Marjolein A Heuvelmans; Matthijs Oudkerk
Journal:  J Thorac Dis       Date:  2015-07       Impact factor: 2.895

3.  What do we know about ground-glass opacity nodules in the lung?

Authors:  Choon-Taek Lee
Journal:  Transl Lung Cancer Res       Date:  2015-10

Review 4.  Screening for lung cancer with low-dose computed tomography: a review of current status.

Authors:  Henry M Marshall; Rayleen V Bowman; Ian A Yang; Kwun M Fong; Christine D Berg
Journal:  J Thorac Dis       Date:  2013-10       Impact factor: 2.895

Review 5.  Whack-a-mole strategy for multifocal ground glass opacities of the lung.

Authors:  Kenji Suzuki
Journal:  J Thorac Dis       Date:  2017-04       Impact factor: 2.895

6.  Discrimination between transient and persistent subsolid pulmonary nodules on baseline CT using deep transfer learning.

Authors:  Chuxi Huang; Wenhui Lv; Changsheng Zhou; Li Mao; Qinmei Xu; Xinyu Li; Li Qi; Fei Xia; Xiuli Li; Qirui Zhang; Longjiang Zhang; Guangming Lu
Journal:  Eur Radiol       Date:  2020-07-21       Impact factor: 5.315

7.  Optimal management of pulmonary ground-glass opacity nodules.

Authors:  Yeon Wook Kim; Choon-Taek Lee
Journal:  Transl Lung Cancer Res       Date:  2019-12

8.  [Management of subsolid pulmonary nodules].

Authors:  E Eisenhuber; G Mostbeck; H Prosch; C Schaefer-Prokop
Journal:  Radiologe       Date:  2014-05       Impact factor: 0.635

Review 9.  Lung cancer LDCT screening and mortality reduction - evidence, pitfalls and future perspectives.

Authors:  Matthijs Oudkerk; ShiYuan Liu; Marjolein A Heuvelmans; Joan E Walter; John K Field
Journal:  Nat Rev Clin Oncol       Date:  2020-10-12       Impact factor: 66.675

10.  Segmentectomy for multiple adenocarcinoma presenting as ground-glass opacities after lung cancer surgery.

Authors:  Ai Takeuchi; Masanori Tsuchida; Takehisa Hashimoto; Hirohiko Shinohara; Jun-Ichi Hayashi
Journal:  Gen Thorac Cardiovasc Surg       Date:  2008-08-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.